ES2633287R1 - Método para generar una opción de tratamiento con terpenos - Google Patents

Método para generar una opción de tratamiento con terpenos Download PDF

Info

Publication number
ES2633287R1
ES2633287R1 ES201690015A ES201690015A ES2633287R1 ES 2633287 R1 ES2633287 R1 ES 2633287R1 ES 201690015 A ES201690015 A ES 201690015A ES 201690015 A ES201690015 A ES 201690015A ES 2633287 R1 ES2633287 R1 ES 2633287R1
Authority
ES
Spain
Prior art keywords
terpene
patient
generate
treatment option
observe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201690015A
Other languages
English (en)
Other versions
ES2633287A2 (es
ES2633287B1 (es
Inventor
Sytze Elzinga
Jeffrey C. Raber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Werc Shop LLC
Original Assignee
Werc Shop LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Werc Shop LLC filed Critical Werc Shop LLC
Publication of ES2633287A2 publication Critical patent/ES2633287A2/es
Publication of ES2633287R1 publication Critical patent/ES2633287R1/es
Application granted granted Critical
Publication of ES2633287B1 publication Critical patent/ES2633287B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/115—Natural spices, flavouring agents or condiments; Extracts thereof obtained by distilling, stripping, or recovering of volatiles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/202—Aliphatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/202—Aliphatic compounds
    • A23L27/2024—Aliphatic compounds having oxygen as the only hetero atom
    • A23L27/2026—Hydroxy compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/203—Alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/51—Concentration
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0007—Aliphatic compounds
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0034—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0038—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing more than six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0042—Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0042—Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C11B9/0049—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/02—Recovery or refining of essential oils from raw materials
    • C11B9/022—Refining
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/15—Flavour affecting agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/16—Taste affecting agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para generar una opción de tratamiento con terpenos.#La invención describe un método para generar electrónicamente opciones de tratamiento inhalables o ingeribles para un paciente, comprendiendo: obtener una base de datos de composiciones de terpeno, comprendiendo las composiciones de terpeno identidades y cantidades de compuestos de terpeno; observar la respuesta del paciente a una primera mezcla de terpenos, observar la respuesta del paciente a una segunda mezcla de terpenos, comparar las respuestas a las dos mezclas de terpeno; y determinar un régimen de tratamiento basándose en la comparación.
ES201690015A 2013-09-18 2014-09-18 Método para generar una opción de tratamiento con terpenos Active ES2633287B1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361879281P 2013-09-18 2013-09-18
US61/879,281 2013-09-18
PCT/US2014/056249 WO2015042232A1 (en) 2013-09-18 2014-09-18 Improved terpene-based compositions, processes, methodologies for creation and products thereby

Publications (3)

Publication Number Publication Date
ES2633287A2 ES2633287A2 (es) 2017-09-20
ES2633287R1 true ES2633287R1 (es) 2017-12-12
ES2633287B1 ES2633287B1 (es) 2018-11-21

Family

ID=52668523

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201690015A Active ES2633287B1 (es) 2013-09-18 2014-09-18 Método para generar una opción de tratamiento con terpenos

Country Status (9)

Country Link
US (11) US10774288B2 (es)
JP (1) JP2017501109A (es)
AU (4) AU2014323509A1 (es)
CA (1) CA2923091C (es)
ES (1) ES2633287B1 (es)
GB (1) GB2533241A (es)
IL (1) IL244399A (es)
RU (1) RU2691986C2 (es)
WO (1) WO2015042232A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180781B2 (en) * 2016-08-21 2021-11-23 Insectergy, Llc Biosynthetic cannabinoid production methods
US20160345631A1 (en) 2005-07-19 2016-12-01 James Monsees Portable devices for generating an inhalable vapor
MX384420B (es) 2013-03-15 2025-03-14 Biotech Inst Llc Cultivo, producción, procesamiento y uso de cannabis de especialidad.
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10774288B2 (en) * 2013-09-18 2020-09-15 The Werc Shop, LLC Terpene-based compositions, processes, methodologies for creation and products thereby
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
EP4556040A3 (en) 2013-12-23 2025-07-09 Juul Labs International Inc. Vaporization device systems and methods
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
KR102627987B1 (ko) 2014-12-05 2024-01-22 쥴 랩스, 인크. 교정된 투여량 제어
CA3012599A1 (en) * 2015-01-26 2016-08-04 Matthew W. Giese Systems, apparatuses, and methods for classification
US20170021029A1 (en) * 2015-04-15 2017-01-26 Jeffrey Charles Raber Topical formulations and uses
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
CN105341995A (zh) * 2015-10-27 2016-02-24 深圳瀚星翔科技有限公司 电子烟烟液及其制备方法
SG11201806793TA (en) 2016-02-11 2018-09-27 Juul Labs Inc Fillable vaporizer cartridge and method of filling
CO2018009342A2 (es) 2016-02-11 2018-09-20 Juul Labs Inc Cartuchos de fijación segura para dispositivos vaporizadores
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
GB201604290D0 (en) * 2016-03-14 2016-04-27 Givaudan Sa Perfume compositions
MX2018012685A (es) * 2016-04-18 2019-06-06 Michael Morrow Kenneth Aislamiento de extractos de plantas.
WO2017193072A1 (en) * 2016-05-06 2017-11-09 Harvest Direct Enterprises Llc The manufacturing methods, compositions, and medical applications of orally administered cannabis pharmaceuticals
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGENOUS HAIR AND SCALP CARE FORMULATIONS AND METHOD OF USE
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
US20170367386A1 (en) * 2016-06-24 2017-12-28 Allied Concessions Group, Inc. Terpene flavoring compositions
US20180015387A1 (en) * 2016-07-16 2018-01-18 Connoisseur Holdings, Llc System and method of forming a terpene solution
WO2018217803A2 (en) 2017-05-22 2018-11-29 Growblox Life Sciences L.L.C. Myrcene-containing complex mixtures targeting trpv1
US10934472B2 (en) 2017-08-18 2021-03-02 Flotek Chemistry, Llc Compositions comprising non-halogenated solvents for use in oil and/or gas wells and related methods
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
WO2020093170A1 (en) * 2018-11-09 2020-05-14 Cronos Group Inc. Liquid composition for an electronic vapor device
US20220023172A1 (en) 2018-11-29 2022-01-27 Kristina Trujillo Cosmetic compositions and methods of use
US20220193003A1 (en) * 2019-02-08 2022-06-23 Srin Therapeutics, Inc. Cannabinoid compositions and methods of use thereof for immune modulation
CN110283660A (zh) * 2019-06-28 2019-09-27 云南中烟工业有限责任公司 一种微波辅助的烟草保润剂的制备方法及应用
CN110301669A (zh) * 2019-06-28 2019-10-08 云南中烟工业有限责任公司 一种超声波改性的烟草保润剂的制备方法及应用
WO2021011413A1 (en) * 2019-07-12 2021-01-21 Atlas Hemp Company Llc. Methods for isolating essential oils, phytochemicals and pharmaceutically active components from biomass and reconstituting synthetic formulations comprising same
CN110477436A (zh) * 2019-07-31 2019-11-22 南京康齐生物科技有限公司 一种烟用香精缓释粒子的制备方法及应用
CN112335654B (zh) * 2019-08-08 2022-03-18 中国农业科学院植物保护研究所 一种引诱红颈常室茧蜂的组合物、引诱剂及其制备和应用
US20230165807A1 (en) * 2019-12-30 2023-06-01 Calibrated Therapeutics, Llc Compositions including terpenes, cannabinoid oils, or flavonoids and uses thereof
AU2021264542B2 (en) * 2020-05-01 2024-10-17 The Procter & Gamble Company Mint flavor compositions
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US12017506B2 (en) 2020-08-20 2024-06-25 Denso International America, Inc. Passenger cabin air control systems and methods
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
US12269315B2 (en) 2020-08-20 2025-04-08 Denso International America, Inc. Systems and methods for measuring and managing odor brought into rental vehicles
US12251991B2 (en) 2020-08-20 2025-03-18 Denso International America, Inc. Humidity control for olfaction sensors
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US20220204430A1 (en) * 2020-12-31 2022-06-30 The Werc Shop, LLC Stereoisomer-specific cannabis formulations and analysis
KR20230154960A (ko) * 2021-03-09 2023-11-09 시므라이즈 아게 발향 물질 (odoriferous substance) 로서 2,6,6-트리메틸-노르피난-2-올
US20230028026A1 (en) * 2021-07-13 2023-01-26 Jupiter Research, Llc Methods and apparatus for pretreating an atomizer

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989646A (en) * 1968-10-30 1976-11-02 Scm Corporation Synthetic lavandin oil
JPH0757734B2 (ja) * 1990-10-09 1995-06-21 呉羽化学工業株式会社 鎮静用香料組成物および香粧品
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6458408B1 (en) * 2000-06-05 2002-10-01 Firmenich Sa Process for producing washed citrus oil flavors
DE10051427C1 (de) 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
JP4846947B2 (ja) * 2000-11-24 2011-12-28 小林製薬株式会社 機能性食品またはその特定成分を含むオーダーメイド免疫活性化組成物
WO2002064722A2 (en) 2001-02-14 2002-08-22 The Procter & Gamble Company Automatic dishwashing compositions comprising diacyl peroxide bleach and blooming perfume
JP2003119490A (ja) * 2001-08-08 2003-04-23 Shiseido Co Ltd 精神鎮静用香料組成物
GB2381450B (en) 2001-10-31 2006-05-31 Gw Pharma Ltd Compositions for administration of natural or synthetic cannabinoids by vaporisation
JP2003190264A (ja) 2001-12-25 2003-07-08 Kiyomitsu Kawasaki 環境用芳香消臭組成物及び該環境用芳香消臭組成物を含有する環境用芳香消臭剤
WO2003063847A1 (en) 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB0202385D0 (en) 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
TW200413019A (en) * 2002-08-09 2004-08-01 Kao Corp Perfume composition
US7344736B2 (en) 2002-08-14 2008-03-18 Gw Pharma Limited Extraction of pharmaceutically active components from plant materials
GB2391865B (en) 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
MXJL03000020A (es) * 2003-07-21 2005-01-25 Armando Ulises Chavez Martinez Obtencion de aceite centrifugado tipo "c" de limon mediante la extraccion de la mezcla esencias-ceras.
EP1768647B1 (en) 2004-06-17 2012-08-08 Virun, Inc. Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agent
US20090155381A1 (en) * 2005-09-08 2009-06-18 Regina Goralczyc Method of treatment or prevention of age-related macular degeneration
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
GB2438682A (en) 2006-06-01 2007-12-05 Gw Pharma Ltd New use for cannabinoids
US8481085B2 (en) 2006-06-15 2013-07-09 Gw Pharma Limited Pharmaceutical compositions comprising cannabigerol
GB2439393B (en) 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
US9155769B2 (en) 2006-07-07 2015-10-13 The Procter & Gamble Co Flavor oils with reduced dimethyl sulfoxide content and use in oral compositions
GB2448535A (en) 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
US9035130B2 (en) 2007-05-31 2015-05-19 Gw Pharma Limited Reference plant, a method for its production, extracts obtained therefrom and their use
GB2449691A (en) 2007-05-31 2008-12-03 Gw Pharma Ltd A reference plant lacking medicinal active compound expression
BRPI0910268B8 (pt) 2008-03-19 2021-05-25 Tyratech Inc composição para controlar uma praga alvo, formulação antiparasitária, uso da dita composição, e método para produzir um agente aperfeiçoado para o controle de uma praga alvo
KR101072040B1 (ko) * 2008-10-20 2011-10-10 (주)아모레퍼시픽 섬백리향의 향취를 재현한 향료 조성물
GB0905840D0 (en) 2009-04-06 2009-05-20 Sagentia Ltd Apparatus and methods
ES2547309T3 (es) 2009-10-19 2015-10-05 Symrise Ag Composiciones que contienen fragancias, que comprenden nonanoato de cetilo y/o nonanoato de estearilo
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
NL2004835C2 (en) * 2010-06-07 2011-12-08 Univ Leiden Process for extracting materials from biological material.
KR101758099B1 (ko) 2010-11-12 2017-07-18 (주)아모레퍼시픽 한방 열매 향취를 재현한 향료 조성물 및 이를 함유하는 피부 외용제 조성물
US20120231083A1 (en) 2010-11-18 2012-09-13 The Board Of Trustees Of The University Of Illinois Sustained release cannabinoid medicaments
US8642645B2 (en) 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
FR2975939B1 (fr) 2011-06-01 2014-05-09 Hexcel Reinforcements Ruban voile presentant une resistance au delaminage amelioree
GB201111261D0 (en) 2011-07-01 2011-08-17 Gw Pharma Ltd Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB201117956D0 (en) 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
GB2496687A (en) 2011-11-21 2013-05-22 Gw Pharma Ltd Tetrahydrocannabivarin (THCV) in the protection of pancreatic islet cells
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
US20140166028A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
CA2895805A1 (en) 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
US10639439B2 (en) * 2013-01-30 2020-05-05 Midwest Pharmaceuticals, Llc Smokeless THC and administration method thereof
MX384420B (es) * 2013-03-15 2025-03-14 Biotech Inst Llc Cultivo, producción, procesamiento y uso de cannabis de especialidad.
US10774288B2 (en) * 2013-09-18 2020-09-15 The Werc Shop, LLC Terpene-based compositions, processes, methodologies for creation and products thereby
US10406186B2 (en) 2015-01-31 2019-09-10 Constance Therapeutics, Inc. Cannabis oil extracts and compositions
US10501432B2 (en) 2016-04-01 2019-12-10 Waters Technologies Corporation Chiral separation of Δ8-THC, Δ9-THC, and related enantiomers using CO2-based chromatography
US10675264B2 (en) 2017-02-07 2020-06-09 Elevate Technologies Llc Terpene-based compositions, methods of preparations and uses thereof
US10654823B2 (en) * 2017-09-09 2020-05-19 Scientific Holdings, Llc Transparent glassy cannabinoid compositions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ethan B Russo. TAMING THC: POTENTIAL CANNABIS SYNERGY AND PHYTOCANNABINOID-TERPENOID ENTOURAGE EFFECTS : PHYTOCANNABINOID-TERPENOID ENTOURAGE EFFECTS. BRITISH JOURNAL OF PHARMACOLOGY, 20110801 Wiley-Blackwell, UK. , 01/08/2011, Vol. 163, Nº 7, Páginas 1344 - 1364 ISSN 0007-1188, (DOI: doi:10.1111/j.1476-5381.2011.01238.x) Tablas 1 y 2, página 1353, columna 2, página 1356 *
Gertsch Juerg et al. PHYTOCANNABINOIDS BEYOND THE CANNABIS PLANT - DO THEY EXIST?. British Journal of Pharmacology JUN 2010. , 31/05/2010, Vol. 160, Nº 3, Páginas 523-529 ISSN 0007-1188(print) ISSN 1476-5381(electronic), (DOI: doi:10.1111/j.1476-5381.2010.00745.x) resumen, tablas 1 y 2 *
Hognadottir A et al. IDENTIFICATION OF AROMA ACTIVE COMPOUNDS IN ORANGE ESSENCE OIL USING GAS CHROMATOGRAPHY-OLFACTOMETRY AND GAS CHROMATOGRAPHY-MASS SPECTROMETRY. Journal of Chromatograp, 20030523 ELSEVIER, AMSTERDAM, NL. Chankvetadze B; Fanali S, 23/05/2003, Vol. 998, Nº 1-2, Páginas 201 - 211 ISSN 0021-9673, (DOI: doi:10.1016/S0021-9673(03)00524-7) resumen, tabla 1 *

Also Published As

Publication number Publication date
IL244399A0 (en) 2016-04-21
ES2633287A2 (es) 2017-09-20
RU2691986C2 (ru) 2019-06-19
AU2014323509A1 (en) 2016-03-17
US20250011681A1 (en) 2025-01-09
CA2923091C (en) 2021-12-21
IL244399A (en) 2017-02-28
AU2022201901A1 (en) 2022-04-07
US20240318097A1 (en) 2024-09-26
WO2015042232A1 (en) 2015-03-26
ES2633287B1 (es) 2018-11-21
US20210071104A1 (en) 2021-03-11
US20240327750A1 (en) 2024-10-03
CA2923091A1 (en) 2015-03-26
US20150080265A1 (en) 2015-03-19
US20210017468A1 (en) 2021-01-21
GB2533241A (en) 2016-06-15
AU2018201704A1 (en) 2018-04-05
US12275914B2 (en) 2025-04-15
AU2020201067A1 (en) 2020-03-05
GB201603724D0 (en) 2016-04-20
RU2016107794A (ru) 2017-10-23
US11884895B2 (en) 2024-01-30
US20210071105A1 (en) 2021-03-11
US20240110125A1 (en) 2024-04-04
US11773345B2 (en) 2023-10-03
US10774288B2 (en) 2020-09-15
US20240309288A1 (en) 2024-09-19
JP2017501109A (ja) 2017-01-12
US11773344B2 (en) 2023-10-03
US20240309289A1 (en) 2024-09-19
US20240110124A1 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
ES2633287R1 (es) Método para generar una opción de tratamiento con terpenos
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1124436T1 (el) Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια
CY1123996T1 (el) Υποκατεστημενα παραγωγα οξοπυριδινης
CY1125436T1 (el) Αναστολεις dna-pk
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
MX380147B (es) Formas de dosificacion de ruxolitinib de liberacion sostenida.
WO2015153959A3 (en) Small molecule inhibitors of mcl-1 and uses thereof
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EP3500255A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
BR112018005145A2 (pt) formulações de nicotina inaláveis e métodos de fabricação e utilização das mesmas
EA201690513A1 (ru) Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний
WO2014197816A8 (en) Stimulus responsive nanocomplexes and methods of use thereof
SV2017005412A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
MX2016010328A (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
MX392182B (es) Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
MX381102B (es) Benralizumab para usarse en el tratamiento de asma incrementando el volumen espiratorio forzado.
EP3383397A4 (en) PHARMACEUTICAL COMPOSITIONS WITH DORAVIRIN, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDIN
DOP2015000175A (es) Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2633287

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20181121